Revolution Medicines Inc. Common Stock vs State Street SPDR S&P Homebuilders ETF — how do they compare? Revolution Medicines Inc. Common Stock trades at $192.62 (market cap $40.32B), while State Street SPDR S&P Homebuilders ETF trades at $94.76 (market cap $1.49B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 27.1× State Street SPDR S&P Homebuilders ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| RVMD | XHB | |
|---|---|---|
Market Cap | $40.32B | $1.49B |
Volume | 4,855,734 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $221.15 | $121.36 |
52-Week Low | $47.50 | $94.86 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XHB, the SPDR S&P Homebuilders ETF, trades at $94.65, down 0.25% on the day. Technical indicators are bearish, with moving averages signaling sell pressure and oscillators neutral. The ETF tracks the homebuilding sector, which faces headwinds from high mortgage rates but potential tailwinds from new housing affordability legislation and institutional interest.
The outlook for XHB is mixed, balancing sector-specific risks like rising rates against legislative support and valuation opportunities. Investment appeal hinges on a housing market recovery, with risks including economic sensitivity and inventory constraints. Sentiment is cautious but notes historical buying signals at current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →